Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic s Lender Laurus Converts $650,000 in Debt into Stock

NEW YORK, March 31 (GenomeWeb News) - Laurus Master Fund has converted into stock an additional $650,000 of a secured convertable term note, the company said in an SEC filing -- the second debt-to-equity conversion with the bank in one week.

 

The original note was issued in the principal amount of $2.8 million, and the debt-to-equity conversion equated to 1.25 million shares. The first conversion, announced on March 18, equated to $1.8 million of the outstanding debt, and 10 percent of the Transgenomic's market capitalization.

 

 on a $7.5 million revolving credit facility. Mitchell Murphy, Transgenomic's interim-CFO, told GenomeWeb News that this amount translated into approximately 10 percent of the company's current market capitalization.

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.